Cipla Limited has announced a revision to its Environmental, Social, and Governance (ESG) rating for FY 2024-25 by NSE Sustainability & Analytics Limited. The score has been adjusted downward from 66 to 65. The company attributes this potential revision to a product recall initiated in January 2026 by its wholly owned subsidiary, Cipla USA Inc. The formal communication regarding this change was received on February 25, 2026.
Disclosure of ESG Rating Revision
Pharma major Cipla Limited issued an official intimation on February 26, 2026, regarding a recent change in its ESG assessment. This disclosure was made to both the BSE Limited and the National Stock Exchange of India Limited, adhering to statutory reporting requirements.
Details of the Revised Rating
The SEBI-registered ESG Rating Provider, NSE Sustainability & Analytics Limited, has formally revised Cipla’s ESG rating for the financial year 2024–25. The score has been lowered from the previous rating of 66 to 65.
Reason for Downgrade
Management notes that this revision is potentially due to an operational event that occurred in January 2026. Specifically, the rating adjustment is linked to a product recall executed by Cipla USA Inc., which is a wholly owned subsidiary of the Company.
Timeline of Receipt
The official communication detailing this revised ESG rating was received by Cipla from NSE Sustainability on February 25, 2026, at 1830 hours IST. The company confirmed that it has taken this information on record and notified the exchanges accordingly.
Source: BSE
